Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FCER2 | P06734 | 4/20 | 0.48 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
| ▸ | NPY4R | P50391 | 5/20 | 0.48 |
| ▸ | NPY1R | P25929 | 3/20 | 0.48 |
| ▸ | NPY2R | P49146 | 2/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.46 |
| ▸ | CTSK | P43235 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP3 | P08254 | 1/20 | 0.45 |
| ▸ | MMP7 | P09237 | 1/20 | 0.45 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17147126 | 0.88 | NPY4R (0.59) | NPY4RNPY1RNPY2RNPY5ROPRD1 | |
| SCHEMBL31185441 | 0.86 | LTA4H (0.62) | FCER2MMP1LTA4HMMP2MMP3 | |
| SCHEMBL30626017 | 0.86 | LTA4H (0.62) | FCER2MMP1LTA4HMMP2MMP3 | |
| SCHEMBL12057953 | 0.86 | LTA4H (0.62) | FCER2MMP1LTA4HMMP2MMP3 | |
| SCHEMBL12038997 | 0.86 | LTA4H (0.62) | FCER2MMP1LTA4HMMP2MMP3 | |
| SCHEMBL2487473 | 0.86 | LTA4H (0.62) | FCER2MMP1LTA4HMMP2MMP3 | |
| Acetic Acid SCHEMBL31115136 | 0.85 | LTA4H (0.61) | FCER2MMP1LTA4HOPRD1KISS1R | |
| Hydrochloric Acid SCHEMBL30449237 | 0.85 | LTA4H (0.61) | FCER2MMP1LTA4HOPRD1KISS1R | |
| Hydrochloric Acid SCHEMBL31115145 | 0.85 | LTA4H (0.61) | FCER2MMP1LTA4HOPRD1KISS1R | |
| Acetic Acid SCHEMBL31115148 | 0.85 | LTA4H (0.61) | FCER2MMP1LTA4HOPRD1KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070197577-A1 | Inhibitors of anthrax lethal factor | CENGENT THERAPEUTICS (US) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197577-A1 | Inhibitors of anthrax lethal factor | APAF1, ANTXR2, LITAF | FCER2 3098/4885MMP1 950/4885NPY4R 4772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.